Navigation Links
Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier
Date:6/9/2009

Roche to fund evaluation of Raptor's proprietary NeuroTrans(TM) technology

NOVATO, Calif., June 9 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced that it has entered a collaboration and licensing agreement with Roche (SWX: ROG.VX; RO.S, OTCQX: RHHBY) to evaluate therapeutic delivery across the blood-brain barrier, ("BBB") starting with Raptor's proprietary NeuroTrans(TM) BBB transporter platform. Under terms of the agreement, Roche will fund studies of select molecules attached to Raptor's proprietary NeuroTrans(TM), a derivative of the receptor-associated protein ("RAP"). The agreement provides Roche with an exclusive worldwide license to NeuroTrans(TM) for use in the delivery of diagnostic and therapeutic molecules across the BBB.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO )

Scientists at Raptor and Roche will actively collaborate on the project. Raptor will receive an initial upfront fee for the collaboration to cover its portion of the initial studies, along with development milestone payments and royalties in exchange for the licensing of NeuroTrans(TM).

Todd C. Zankel, Ph.D., Chief Scientific Officer and co-founder of Raptor, stated, "We are excited to be collaborating with Roche, a world leader in pharmaceutical research. We believe that by combining our knowledge of the work done in the area of BBB transport and the resources of Roche, our collaboration is well positioned to make significant progress in a critical and challenging area in medical research."

Crossing the BBB remains a major obstacle to effectively treating most neurological disorders. While medical research has identified hundreds
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp.
2. Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp.
3. Smith & Nephew Endoscopys BIORAPTOR(TM) 2.3 PK Suture Anchor Provides Secure Repair for Shoulder, Hip Instability
4. The Glendale Raptors Set Dates for Youth Rugby League and USA Rugby Youth Academy
5. Glendale Raptors Join Four Points by Sheraton Denver Southeast and Animal Planets Dr. Kevin Fitzgerald for Second Annual Halloween Costume Drive & Halloween Party for Kunsberg School at National Jewish Medical and Research Center
6. Raptor Pharmaceuticals Corp. to Present at Two Upcoming Healthcare Conferences
7. Smith & Nephew Endoscopys OSTEORAPTOR(TM) Anchor Provides Bioabsorbable Solution for Labral Tears in the Hip and Shoulder
8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
9. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
10. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
11. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Children,s Hospitals and Clinics o... Leapfrog Top Hospitals Award. Children,s - Minne...among the best in the nation while also attaining ...og survey is the only national, public comparison ...es for common procedures, infection rates, and saf...
(Date:12/3/2009).../PRNewswire-Asia/ -- Long believed to provide a va...important ingredients in global,cuisine, has seen ..., The timing of this ginger demand increa...rd price pressures in a way that has speculators w...emand hysteria over garlic. Garlic, also,believed ...
(Date:12/3/2009)...., Dec. 3 Christian Audigier appar...nd Premier Shopping Event for Project Angel Food, ...ar prices. The event kicks off on Thursday, Decem...ocated at 9900 Wilshire Boulevard (formerly Robins... www.divinedesign.org for more information and t...
(Date:12/3/2009)..., Dec. 3 We are closer than ever b...es affordable, quality care for all. The American... their representatives and voice their support for...om ANA at: http://inr.mediaseed.tv/ANA_37124/ ,...m that focuses on wellness and prevention, a high-...
(Date:12/3/2009)... sulfonylureas, but each patient will be different...thDay News) -- A class of drugs still taken by mi...d with a higher risk of dying and heart failure th... , , Sulfonylureas, long a mainstay of diabetes...a study of oral anti-diabetes drugs, but doctors s...
Breaking Medicine News(10 mins):Health News:Children's Hospitals and Clinics of Minnesota Receives National Recognition for Quality and Efficiency 2Health News:Ginger Prices Could Skyrocket on H1N1 Fears 2Health News:Christian Audigier Represented at Divine Design for Project Angel Food 2Health News:VIDEO from Medialink and the American Nurses Association (ANA): American Nurses Association Urges All Americans to Take Part in Health Care Reform Debate 2Health News:Diabetes Drugs Go Head-to-Head in Study 2Health News:Diabetes Drugs Go Head-to-Head in Study 3
...roLipo,PLUS(TM), an FDA-cleared, minimally invasiv...d melting unwanted fat, resulting in collagen remo...es 1064 nm and 1319 nm wavelengths in,one laser fo...ients who are not candidates for traditional lipos...
...ing-edge of intraoperative imaging , , CHICAG....com/healthcare ) will highlight its family of...ng outstanding image quality, streamlined workflow...er 30 to December 5 at McCormick Place (Booth #922...
...d with Vinson,Hall Retirement Community (VHRC), in... will participate in a commemoration of the event ...in Washington, D.C. One was a naval officer,durin...or serving seniors. , The survivor and VHRC ...
...n dollars to qualified recipients , , ATLANT...onor 31 recipients of the 2008 UCB Family Epilepsy...Sunday, December 7 during the American Epilepsy So... higher learning. , , Each year, the UCB Fami...
...Commercial - , , CINCINNATI, Dec. 1 Cres...itening Expressions and flavor expert Emeril Lag...test in search of a new catch phrase that best cap...America voted it the winning phrase. , , To v...
... literature,film and history have to do with medic... Panush, M.D., Chair of Medicine at Saint Barnabas...ogram bringing humanities to the bedside for,resid...wing group of physicians and,medical educators who...
Other Medicine News:Health News:Sciton Introduces ProLipo PLUS(TM), the Most Robust Laser-Assisted Lipolysis System Available 2Health News:Siemens Next-Generation of C-Arms Demonstrate Precision Imaging and Ease of Use 2Health News:Siemens Next-Generation of C-Arms Demonstrate Precision Imaging and Ease of Use 3Health News:Individuals Associated with Vinson Hall Retirement Community, Who Survived Pearl Harbor Attack, to Participate in Navy Memorial Event December 7 2Health News:Unique Scholarship Helps People Affected by Epilepsy Fulfill Life Ambitions 2Health News:Unique Scholarship Helps People Affected by Epilepsy Fulfill Life Ambitions 3Health News:Unique Scholarship Helps People Affected by Epilepsy Fulfill Life Ambitions 4Health News:Video: America Votes Crest Whitening Expressions Is FanTaste-ic! 2Health News:Saint Barnabas Medical Center Pioneers New Program Bringing Humanities and Humanism to Medicine 2Health News:Saint Barnabas Medical Center Pioneers New Program Bringing Humanities and Humanism to Medicine 3Health News:Saint Barnabas Medical Center Pioneers New Program Bringing Humanities and Humanism to Medicine 4
(Date:12/4/2009).... 4 Northwest Biotherape...n Board: NWBO) announced today that the US Patent ...ation on a system for automation of the initial st...4; therapeutic cancer vaccines. These initial man...ration of dendritic cells (which are the critical ...
(Date:12/4/2009)..., Dec. 4 AstraZeneca (NY...rug Administration (FDA) has approved once-daily S...lease Tablets as adjunctive (add-on) treatment to ...sorder (MDD). SEROQUEL XR is the only medication i...r depressive disorder as adjunctive therapy and ac...
(Date:12/4/2009)...ec. 4 Depression, anxiety disorder...y Disorder (ADHD), sleep disorder and migraine: Th...more often in people who said they had been diagno... diagnosis, according to a survey of approximately... from " CNS-Related Comorbidities in Individuals w...
Breaking Medicine Technology:Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Beckman Coulter Completes Acquisition of Olympus Lab Based Diagnostics Business 13318 1Beckman Coulter Completes Acquisition of Olympus Lab Based Diagnostics Business 13318 2Transcept Pharmaceuticals to Hold Conference Call on Agreement with Purdue Pharmaceutical Products L P to Commercialize Intermezzo 28R 29 in the Unit 53435 1Transcept Pharmaceuticals to Hold Conference Call on Agreement with Purdue Pharmaceutical Products L P to Commercialize Intermezzo 28R 29 in the Unit 53435 2Scientists ID First Human With Gorilla Strain of HIV 53433 1Scientists ID First Human With Gorilla Strain of HIV 53433 2
...scular Target from Lexicon,s Genetic,Research -, T...stCall/ --,Lexicon Pharmaceuticals, Inc. today rep...ing that antibodies directed to a,potential new ta...ly lower triglycerides and cholesterol. Research s... ANGPTL4 may have therapeutic,application in the t...
...PRNewswire-FirstCall/ -- Nuvelo,Inc. (Nasdaq: NUV...coagulation with rNAPc2 To Help Eliminate MACE)/TI...e anticoagulant protein c2,(rNAPc2) in patients wi...a evaluating rNAPc2 in mouse models of colorectal,...ism of NU172, a,short-acting, direct thrombin inhi...
Other Medicine Technology:Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 2Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 3Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 4Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 5Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst,Congress of the International Society on Thrombosis and Haemostasis 2Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst,Congress of the International Society on Thrombosis and Haemostasis 3
Perneczky Diamond Dissectors
Cone Ring Curette
Semmes Spinal Fusion Curette
Karlin Lumbar Microdiscectomy Curette
Medicine Products: